China Universal Asset Management Co., Ltd. Mirum Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 9,831 shares of MIRM stock, worth $506,198. This represents 0.04% of its overall portfolio holdings.
Number of Shares
9,831
Previous 10,179
3.42%
Holding current value
$506,198
Previous $420,000
5.24%
% of portfolio
0.04%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding MIRM
# of Institutions
227Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$350 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$245 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$167 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$144 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$131 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.89B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...